Search Results - "Alves, Marclesson S."

Decision-Making Game for Simulation of Breast Cancer Biopsy and Treatment by Barbosa, Rafael G., Rodrigues, Maria Andreia F., de Oliveira, Thiago R. C., Madeira, Samuel P., de Figueiredo, Juliana A., Alves, Marclesson S., Medeiros, Maria Angelina S., Filho, Ricardo L. Cabral

“…Game-based simulations using real-world case scenarios can benefit health professionals and students regarding experience in decision-making. In this work,…”
Get full text

Assessment of early tumor response to induction chemotherapy (IC) in locally advanced squamous-cell carcinoma of head and neck (LASCCHN) with 18FDG PET-CT: A prospective trial by Nicolau, Ulisses Ribaldo, Lima, Eduardo Nobrega Pereira, Alves, Marclesson S., Oliveira, Thiago Bueno, Jesus, Victor Hugo Fonseca, Paiva, Tadeu Ferreira, Cezana, Loureno, Silva, Virgilio Sousa, Pinto, Paula Nicole, Porto, Gislaine Machado, Pellizzon, Antonio Cassio Assis, Carvalho, Genival Barbosa, Kowalski, Luiz Paulo

“…Abstract only 6017 Background: Response to IC with triplet regimens adding taxanes to cisplatin and 5-fluorouracil (TPF), followed by chemoradiotherapy (CRT)…”
Get full text

Comparison of bevacizumab versus pemetrexed in combination with platinum-based doublets in first-line treatment of advanced non-small cell lung cancer by Pereira, Augusto Akikubo Rodrigues, Martins, Sandro José, Lessa, Rafael Costa, Pinto, Flavio Augusto Ismael, Gagliato, Debora De Melo, Santos, Elizabeth S., Rodrigues, Newton Augusto Ferreira, Freitas, Paulo Henrique Aires, Padua, Fernando Vidigal, Alves, Marclesson S., Lima, Geraldine Eltz, Fanelli, Marcello Ferretti, Rinck, Jose A., Dettino, Aldo A., Nicolau, Ulisses Ribaldo, Pereira, Jose Rodrigues, Cruz, Marcelo Rocha De Sousa, Lima, Vladmir C.

“…Abstract only e18078 Background: First-line treatment of advanced nonsquamous non-small cell lung cancer (NSCLC) with platinum-based doublets, including…”
Get full text

Association of hypothyroidism with improved outcomes in first-line treatment of renal cell carcinoma with sunitinib by Pinto, Flavio Augusto Ismael, Pereira, Augusto Akikubo Rodrigues, Formiga, Maria Nirvana, Fanelli, Marcello Ferretti, Chinen, Ludmilla T. D., Lima, Vladmir C., De Melo Gagliato, Debora, Santos, Elzabeth Santana, Dettino, Aldo A., Sousa, Carlos Eduardo Pires, Rodrigues, Newton Augusto Ferreira, Padua, Fernando Vidigal, Freitas, Paulo Henrique Aires, Alves, Marclesson S., Nicolau, Ulisses Ribaldo, Lisboa, Joyce, Ribeiro, Adriana G., Jesus, Victor Hugo Fonseca, Rinck, José A.

“…Abstract only 466 Background: Sunitinib, a multitarget tyrosine-kinase inhibitor, has become a standard of care for first-line low and intermediate risk…”
Get full text